CSIMarket


Terms Beginning with A
       
       
 

ANDA Abbreviated New Drug Application

Health Care Term


ANDA (Abbreviated New Drug Application) is a regulatory submission that pharmaceutical companies submit to the Food and Drug Administration (FDA) to seek approval to sell generic drugs. A generic drug is a medication that is bioequivalent to a brand-name drug in terms of dosage, safety, strength, quality, and intended use.

The ANDA submission process is a critical step in the drug development and approval process for generic drugs. It must establish that the proposed generic drug product meets all the same quality, safety, and efficacy standards as the brand-name product. In addition, the ANDA must show that the drug delivery system, dosage form, and labeling are similar to the brand-name product.

The ANDA process saves time and resources for manufacturers of generic drugs, as they do not need to demonstrate the safety and efficacy of the active ingredient or conduct clinical trials. Instead, they must show that their product is the bioequivalent of the brand-name product.

Once approved, generic drugs are typically less expensive than their brand-name counterparts, making them more accessible and affordable for patients. The availability of generic drugs also increases competition in the market, which helps to lower drug prices even further.

Overall, ANDA plays a crucial role in the healthcare industry by ensuring that patients have access to safe, effective, and affordable medications.


   
     

ANDA Abbreviated New Drug Application

Health Care Term


ANDA (Abbreviated New Drug Application) is a regulatory submission that pharmaceutical companies submit to the Food and Drug Administration (FDA) to seek approval to sell generic drugs. A generic drug is a medication that is bioequivalent to a brand-name drug in terms of dosage, safety, strength, quality, and intended use.

The ANDA submission process is a critical step in the drug development and approval process for generic drugs. It must establish that the proposed generic drug product meets all the same quality, safety, and efficacy standards as the brand-name product. In addition, the ANDA must show that the drug delivery system, dosage form, and labeling are similar to the brand-name product.

The ANDA process saves time and resources for manufacturers of generic drugs, as they do not need to demonstrate the safety and efficacy of the active ingredient or conduct clinical trials. Instead, they must show that their product is the bioequivalent of the brand-name product.

Once approved, generic drugs are typically less expensive than their brand-name counterparts, making them more accessible and affordable for patients. The availability of generic drugs also increases competition in the market, which helps to lower drug prices even further.

Overall, ANDA plays a crucial role in the healthcare industry by ensuring that patients have access to safe, effective, and affordable medications.


Related Health Care Terms
                     
                     
 Adenocarcinoma   Analogues   Arrhythmia  
 Adenosine   ANDA Abbreviated New Drug Application   Arteriosclerosis  
 Adult Stem Cell   Angina   Atherosclerosis  
 Adverse Event   Angiogenesis   Autologous  
 Agonist   Angioplasty   Balloon Angioplasty  
 AIDS   Antagonist   Bioavailability  
 Alkylation Agent   Anti Hypertensive   Biologic Products  
 Allogeneic   Antibody   Biomarker  
 Amino Acid   Antigen   Bradycardia  
 Analgesic   API   Cancer  
               
                  next arrow
 
   


Help

About us

Advertise